Published in Pediatr Neurol on August 01, 2001
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem (2005) 1.95
Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage (2007) 1.88
Profile of altered brain iron acquisition in restless legs syndrome. Brain (2011) 1.48
Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets. NeuroRx (2006) 1.21
Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res (2013) 1.10
Inhibition of DAT function attenuates manganese accumulation in the globus pallidus. Environ Toxicol Pharmacol (2007) 1.01
Brain iron quantification in mild traumatic brain injury: a magnetic field correlation study. AJNR Am J Neuroradiol (2011) 0.99
Diurnal cycle influences peripheral and brain iron levels in mice. J Appl Physiol (1985) (2008) 0.93
Ischemic preconditioning attenuates brain edema after experimental intracerebral hemorrhage. Transl Stroke Res (2012) 0.90
Changing iron content of the mouse brain during development. Metallomics (2012) 0.90
Prenatal inflammation-induced hypoferremia alters dopamine function in the adult offspring in rat: relevance for schizophrenia. PLoS One (2010) 0.90
Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach. Mol Cell Proteomics (2009) 0.88
Iron, the retina and the lens: a focused review. Exp Eye Res (2010) 0.88
Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1-42). J R Soc Interface (2014) 0.85
HFE gene variants, iron, and lipids: a novel connection in Alzheimer's disease. Front Pharmacol (2014) 0.81
A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers. Mov Disord (2013) 0.81
Increased expression of ferritin in cerebral cortex after human traumatic brain injury. Neurol Sci (2012) 0.80
Identifying the threshold of iron deficiency in the central nervous system of the rat by the auditory brainstem response. ASN Neuro (2015) 0.77
Brain iron overload following intracranial haemorrhage. Stroke Vasc Neurol (2016) 0.77
Diurnal variations in brain iron concentrations in BXD RI mice. Neuroscience (2014) 0.76
MRI findings in AOA2: Cerebellar atrophy and abnormal iron detection in dentate nucleus. Neuroimage Clin (2013) 0.75
Correlation of iron deposition and change of gliocyte metabolism in the basal ganglia region evaluated using magnetic resonance imaging techniques: an in vivo study. Arch Med Sci (2016) 0.75
Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value. PLoS One (2017) 0.75
Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis. PLoS Genet (2017) 0.75
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33
Outbreak of clinical mastitis in dairy cows following 'blitz' therapy. Vet Rec (1997) 2.63
Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology (2008) 2.51
Relationship of iron to oligodendrocytes and myelination. Glia (1996) 2.44
Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology (2003) 2.04
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res (1992) 1.69
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res (1990) 1.60
Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J Neurosci Res (2001) 1.38
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group. Am J Obstet Gynecol (1993) 1.31
Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology (2004) 1.28
Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet (2000) 1.27
A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) Brain (1999) 1.22
Cellular management of iron in the brain. J Neurol Sci (1995) 1.11
Altered cellular distribution of iron in the central nervous system of myelin deficient rats. Neuroscience (1990) 1.08
Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience (1999) 1.03
Identification and localization of divalent metal transporter-1 (DMT-1) in term human placenta. Placenta (2000) 1.01
Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res (1994) 0.99
Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol (1997) 0.97
Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res (1999) 0.97
A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol (1995) 0.95
Solitary sciatic nerve lymphoma as an initial manifestation of diffuse neurolymphomatosis. Case report and review of the literature. J Neurosurg (2000) 0.92
A phase I study of active specific intralymphatic immunotherapy (ASILI). Cancer (1978) 0.91
In vitro hypoxia and excitotoxicity in human brain induce calcineurin-Bcl-2 interactions. Neuroscience (2003) 0.87
Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors. J Immunol (1976) 0.84
Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics. J Neuropathol Exp Neurol (1998) 0.84
Decreased CD8 cell-mediated viral suppression and other immunologic characteristics of women who transmit human immunodeficiency virus to their infants. J Infect Dis (1999) 0.83
Intralymphatic infusion of autochthonous tumor cells in canine lymphoma. Int J Radiat Oncol Biol Phys (1976) 0.82
Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines. Vaccine (2009) 0.80
Transferrin in the central nervous system of the shiverer mouse myelin mutant. J Neurosci Res (1993) 0.80
Signals for proinflammatory cytokine secretion by human Schwann cells. J Neuroimmunol (1999) 0.80
Regional intralymphatic infusion (ILI) of irradiated tumor cells with evidence of distant effects. Cancer (1977) 0.77
Intralymphatic immunization: current status. Eur J Cancer (1977) 0.77
Distribution and consequences of cell suspensions following intralymphatic infusion. Bull Cancer (1979) 0.77
Dysmyelinogenesis in caprine beta-mannosidosis: ultrastructural and morphometric studies in fetal optic nerve. Int J Dev Neurosci (1987) 0.77
Secondary in vitro lymphocyte-proliferative responses to syngeneic plasma cell tumors. Cancer Res (1976) 0.75